Injecting hope : can gene therapy financing be the next big opportunity for insurers?
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000cab a2200000 4500 | ||
| 001 | MAP20160014303 | ||
| 003 | MAP | ||
| 005 | 20160428115624.0 | ||
| 008 | 160428e20160401usa|||p |0|||b|eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a34 | ||
| 100 | $0MAPA20160006049$aRao, Anand S. | ||
| 245 | 1 | 0 | $aInjecting hope$b: can gene therapy financing be the next big opportunity for insurers?$cAnand S. Rao |
| 520 | $aRecent developments have brought the ease and precisión of cut-and-paste technology to gene editing. The developments have raised issues of particular interest to insurers, who are well situated to offer protection or financing for genetic diseases or disorders because they are uniqueley able to assess and Price related risks | ||
| 650 | 4 | $0MAPA20080587901$aSeguro de personas | |
| 650 | 4 | $0MAPA20080547424$aGenética | |
| 650 | 4 | $0MAPA20080573867$aSeguro de salud | |
| 650 | 4 | $0MAPA20080553630$aCoberturas | |
| 650 | 4 | $0MAPA20080591878$aMedicina del seguro | |
| 773 | 0 | $wMAP20077100109$tBest's Review$dNew Jersey : A.M. Best Company, 1976-$x1527-5914$g04/04/2016 Volumen 116 Número 12 - abril 2016 , p. 24-26 |